Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06089161 · ClinicalTrials.gov registry record · NA
Personalized Obstructive Sleep Apnea Treatment and Effects on Alzheimer's Disease Biomarkers and Cognition Among Blacks
A NA study of Sleep Apnea, sponsored by University of Miami.
- Recruiting
- Registry status
- NA
- Development phase
- 330
- Enrollment target
- 1
- Study location
NCT06089161: Recruiting NA study of Sleep Apnea, sponsored by University of Miami.
NCT06089161 is a NA study of Sleep Apnea that is actively recruiting participants, run by University of Miami. The registered enrollment target is 330 participants, below the 2,980-participant average among 36 other Sleep Apnea trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06089161, a NA study of Sleep Apnea, is actively recruiting participants, sponsored by University of Miami.
- RECRUITING
- Registry status
- NA
- Development phase
- 330 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to see how effective the Personalized obstructive sleep apnea (OSA) Treatment Adherence Model called PRAISE is in helping the patient stick to the physician recommended OSA treatment plan Positive Airway Pressure (PAP).
Primary Outcome
The proportion of participants who answer yes (meaning a participant acknowledges an average of more than 4 hours of continuous positive airway pressure use) or no (meaning a participant acknowledges an average of less than 4 hours of continuous positive airway pressure use).
Conditions Studied
Interventions
- OTHER Standard of Care
- BEHAVIORAL Personalized OSA Treatment
Study Locations (1)
Florida
- University of Miami - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 330 participants |
| Start Date | 2024-03-19 |
| Est. Completion | 2028-05-31 |
| Phase | NA |
What NCT06089161 shows while recruiting
NCT06089161 is an interventional study that assigns participants to a tested intervention. The registered 330 participants enrollment target is mid-sized for trials with a published cap, below the 2,980-participant average among 36 other Sleep Apnea trials with a reported enrollment target (89% lower).
The record links to 1 condition, with Sleep Apnea appearing as the primary indexed condition, and to 2 interventions - of which Standard of Care is the first listed.
NCT06089161 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT06089161 about?
NCT06089161 is a clinical study titled "Personalized Obstructive Sleep Apnea Treatment and Effects on Alzheimer's Disease Biomarkers and Cognition Among Blacks". The purpose of this research is to see how effective the Personalized obstructive sleep apnea (OSA) Treatment Adherence Model called PRAISE is in helping the patient stick to the physician recommended OSA treatment plan Positive Airway Pressure (PAP).
What is the current status of trial NCT06089161?
This trial is currently recruiting. It is a NA study. The enrollment target is 330 participants. The study started on 2024-03-19. Estimated completion is 2028-05-31.
What conditions does trial NCT06089161 study?
This clinical trial studies the following conditions: Sleep Apnea.
What interventions are being tested in trial NCT06089161?
The interventions under investigation include: Standard of Care (OTHER), Personalized OSA Treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT06089161?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06089161 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sleep Apnea
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06089161's enrollment target sits among peer trials
330 4th of 36 higher than 33 of 36 other Sleep Apnea trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sleep Apnea trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mechanisms of Prediabetic States in Sleep Apnea
RECRUITING · NA
-
Reaching for Equity in Sleep Apnea Treatment (REST) Study
RECRUITING · NA
-
Effect of Hypercapnia Treatment on Respiratory Recovery After Spinal Cord Injury
RECRUITING · NA
-
Janus II Feasibility
RECRUITING · NA
-
Technology-Supported Treatment of Sleep Apnea in Prediabetes
ACTIVE NOT RECRUITING · NA
-
Sleep for Stroke Management and Recovery Trial
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00359684 · 330 participants
Use of Cysteamine in the Treatment of Cystinosis
- NCT03817502 · 330 participants · Phase 3
Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With Schizophrenia
- NCT03922724 · 330 participants · Phase 2
Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma
- NCT03932773 · 330 participants · NA
Multi-site Confirmatory Efficacy Treatment Trial of Combat-related PTSD
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI